Using single protein biomarkers to predict health and disease in diverse patient populations: a new role for assessment of immunoglobulin free light chains.
作者信息
Drayson Mark T
出版信息
Mayo Clin Proc. 2012 Jun;87(6):505-7. doi: 10.1016/j.mayocp.2012.04.004.
Abstract
摘要
相似文献
1
Using single protein biomarkers to predict health and disease in diverse patient populations: a new role for assessment of immunoglobulin free light chains.
Mayo Clin Proc. 2012 Jun;87(6):505-7. doi: 10.1016/j.mayocp.2012.04.004.
2
Polyclonal immunoglobulin free light chain and chronic inflammation.
Mayo Clin Proc. 2012 Oct;87(10):1032-3; author reply 1033. doi: 10.1016/j.mayocp.2012.07.012.
3
Higher serum levels of free ĸ plus λ immunoglobulin light chains ameliorate survival of hemodialysis patients.
Kidney Blood Press Res. 2011;34(5):344-9. doi: 10.1159/000328322. Epub 2011 Jun 3.
4
Comparison of free κ and λ light chain immunoassays and total (bound and free) κ and λ light chain immunoassays.
Rev Invest Clin. 2014 Sep-Oct;66(5):473-4.
5
Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum.
Clin Chem. 1992 Dec;38(12):2454-7.
6
Biological variation of free light chains in serum.
Clin Chim Acta. 2014 Jan 1;427:27-8. doi: 10.1016/j.cca.2013.09.020. Epub 2013 Oct 1.
7
Biological variation of free light chains in serum.
Clin Chim Acta. 2013 Mar 15;418:72. doi: 10.1016/j.cca.2013.01.001. Epub 2013 Jan 11.
8
Immunoglobulin Free Light Chains as Inflammatory Biomarkers of Atrial Fibrillation.
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e009017. doi: 10.1161/CIRCEP.120.009017. Epub 2020 Oct 5.
9
[Serum free light chains: clinical utility].
An Med Interna. 2008 May;25(5):249-50. doi: 10.4321/s0212-71992008000500017.
10
Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.
Leukemia. 2018 Aug;32(8):1815-1818. doi: 10.1038/s41375-018-0041-0. Epub 2018 Apr 20.
引用本文的文献
1
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.
Allergy. 2018 Feb;73(2):328-340. doi: 10.1111/all.13311. Epub 2017 Oct 5.
2
Polyclonal immunoglobulin free light chain and chronic inflammation.
Mayo Clin Proc. 2012 Oct;87(10):1032-3; author reply 1033. doi: 10.1016/j.mayocp.2012.07.012.
本文引用的文献
1
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.
Mayo Clin Proc. 2012 Jun;87(6):517-23. doi: 10.1016/j.mayocp.2012.03.009.
2
Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.
J Clin Oncol. 2012 Apr 1;30(10):1087-94. doi: 10.1200/JCO.2011.39.0310. Epub 2012 Feb 13.
3
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.
Blood. 2011 May 5;117(18):4701-5. doi: 10.1182/blood-2010-10-299529. Epub 2011 Feb 3.
4
5
Lymphocyte sub-population cell counts are associated with the metabolic syndrome and its components in the Vietnam Experience Study.
Atherosclerosis. 2010 Nov;213(1):294-8. doi: 10.1016/j.atherosclerosis.2010.08.047. Epub 2010 Aug 19.
6
Immunoglobulin aggregation leading to Russell body formation is prevented by the antibody light chain.
Blood. 2010 Jan 14;115(2):282-8. doi: 10.1182/blood-2009-07-234864. Epub 2009 Oct 12.
7
Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials.
Blood. 2006 Sep 15;108(6):2013-9. doi: 10.1182/blood-2006-03-008953. Epub 2006 May 25.
8
INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA PROTEINS. CHARACTERISTICS AND LOCALIZATION TO SUBUNITS.
J Exp Med. 1965 Apr 1;121(4):561-75. doi: 10.1084/jem.121.4.561.
9
PHYSICOCHEMICAL PROPERTIES OF BENCE-JONES PROTEINS IN THE FORM OF L-CHAIN DIMERS.
Biochim Biophys Acta. 1965 Jan 25;94:175-82. doi: 10.1016/0926-6585(65)90021-x.
10
Serum test for assessment of patients with Bence Jones myeloma.
Lancet. 2003 Feb 8;361(9356):489-91. doi: 10.1016/S0140-6736(03)12457-9.
Zotero 插件